These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 26055823

  • 1. Implications of Definitive Prostate Cancer Therapy on Soft Tissue Margins and Survival in Patients Undergoing Radical Cystectomy for Bladder Urothelial Cancer.
    Luchey AM, Lin HY, Yue B, Agarwal G, Gilbert SM, Lockhart J, Poch MA, Pow-Sang JM, Spiess PE, Sexton WJ.
    J Urol; 2015 Nov; 194(5):1220-5. PubMed ID: 26055823
    [Abstract] [Full Text] [Related]

  • 2. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [Abstract] [Full Text] [Related]

  • 3. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients.
    Novara G, Svatek RS, Karakiewicz PI, Skinner E, Ficarra V, Fradet Y, Lotan Y, Isbarn H, Capitanio U, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Tilki D, Dinney CP, Lerner SP, Schoenberg M, Volkmer BG, Sagalowsky AI, Shariat SF.
    J Urol; 2010 Jun; 183(6):2165-70. PubMed ID: 20399473
    [Abstract] [Full Text] [Related]

  • 4. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
    Mitra AP, Alemozaffar M, Harris BN, Schuckman AK, Skinner EC, Daneshmand S.
    Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
    [Abstract] [Full Text] [Related]

  • 5. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
    Aziz A, Shariat SF, Roghmann F, Brookman-May S, Stief CG, Rink M, Chun FK, Fisch M, Novotny V, Froehner M, Wirth MP, Schnabel MJ, Fritsche HM, Burger M, Pycha A, Brisuda A, Babjuk M, Vallo S, Haferkamp A, Roigas J, Noldus J, Stredele R, Volkmer B, Bastian PJ, Xylinas E, May M.
    BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
    [Abstract] [Full Text] [Related]

  • 6. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP, Clark P, Miranda G, Cai J, Groshen S, Skinner DG.
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [Abstract] [Full Text] [Related]

  • 7. Radical cystectomy for bladder cancer after definitive prostate cancer treatment.
    Schuster TG, Marcovich R, Sheffield J, Montie JE, Lee CT.
    Urology; 2003 Feb; 61(2):342-7; discussion 347. PubMed ID: 12597943
    [Abstract] [Full Text] [Related]

  • 8. Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy.
    May M, Brookman-May S, Burger M, Gilfrich C, Fritsche HM, Rink M, Chun F, Fisch M, Roghmann F, Noldus J, Mayr R, Pycha A, Novotny V, Wirth M, Vallo S, Haferkamp A, Roigas J, Brisuda A, Stredele R, Volkmer B, Dechet C, Schnabel M, Denzinger S, Stief CG, Bastian PJ, Aziz A.
    Ann Surg Oncol; 2014 Nov; 21(12):4034-40. PubMed ID: 24895114
    [Abstract] [Full Text] [Related]

  • 9. A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy.
    Zargar-Shoshtari K, Zargar H, Lotan Y, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black PC.
    J Urol; 2016 Jan; 195(1):53-9. PubMed ID: 26205531
    [Abstract] [Full Text] [Related]

  • 10. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
    May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L, Herrmann E, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M.
    Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
    [Abstract] [Full Text] [Related]

  • 11. Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy.
    Knoedler JJ, Boorjian SA, Tollefson MK, Cheville JC, Thapa P, Tarrell RF, Frank I.
    BJU Int; 2014 Dec; 114(6):832-6. PubMed ID: 24119219
    [Abstract] [Full Text] [Related]

  • 12. Urethrectomy following cystectomy for bladder cancer in men: practice patterns and impact on survival.
    Nelles JL, Konety BR, Saigal C, Pace J, Lai J, Urologic Diseases in America Project.
    J Urol; 2008 Nov; 180(5):1933-6; discussion 1936-7. PubMed ID: 18801516
    [Abstract] [Full Text] [Related]

  • 13. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
    Frazier HA, Robertson JE, Dodge RK, Paulson DF.
    Cancer; 1993 Jun 15; 71(12):3993-4001. PubMed ID: 8508365
    [Abstract] [Full Text] [Related]

  • 14. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M.
    Ann Acad Med Stetin; 2000 Jun 15; 46():217-29. PubMed ID: 11712306
    [Abstract] [Full Text] [Related]

  • 15. Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle: results from a nationwide case-control study.
    Neuzillet Y, Soulie M, Larre S, Roupret M, Defortescu G, Murez T, Pignot G, Descazeaud A, Patard JJ, Bigot P, Salomon L, Colin P, Rigaud J, Bastide C, Durand X, Valeri A, Kleinclauss F, Bruyere F, Pfister C, Comité de Cancérologie de l'Association Française d'Urologie (CCAFU).
    BJU Int; 2013 Jun 15; 111(8):1253-60. PubMed ID: 23331375
    [Abstract] [Full Text] [Related]

  • 16. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S, Ricci C, Gaeta M, Ratti D, Macchi A, Casellato S, Bozzini G, Carmignani L.
    J Urol; 2012 Dec 15; 188(6):2046-54. PubMed ID: 23083867
    [Abstract] [Full Text] [Related]

  • 17. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database.
    Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, Henning JM, Stier DM, Carroll PR.
    J Urol; 2000 Apr 15; 163(4):1171-7; quiz 1295. PubMed ID: 10737489
    [Abstract] [Full Text] [Related]

  • 18. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
    Todenhöfer T, Renninger M, Schwentner C, Stenzl A, Gakis G.
    BJU Int; 2012 Dec 15; 110(11 Pt B):E533-40. PubMed ID: 22578156
    [Abstract] [Full Text] [Related]

  • 19. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF, Bolenz C, Godoy G, Fradet Y, Ashfaq R, Karakiewicz PI, Isbarn H, Jeldres C, Rigaud J, Sagalowsky AI, Lotan Y.
    J Urol; 2009 Jul 15; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [Abstract] [Full Text] [Related]

  • 20. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA, Keren Paz GE, Chen LY, Herr HW, Dalbagni G.
    BJU Int; 2013 Jul 15; 112(1):54-9. PubMed ID: 23146082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.